![Anneliese Monden](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anneliese Monden
Direttore/Membro del Consiglio presso Man & Science NV
Posizioni attive di Anneliese Monden
Società | Posizione | Inizio | Fine |
---|---|---|---|
Man & Science NV
![]() Man & Science NV Pharmaceuticals: MajorHealth Technology Man & Science NV is a Belgian medical device company that develops a novel, minimally invasive, battery-free neurostimulation system to reduce the pain and frequency of severe headache attacks. The company is based in Mont-Saint-Guibert, Belgium, and has subsidiaries in Norway. The company's therapies allow headache patients to return to a normal, pain-free life. The company's team consists of experienced scientists, engineers, clinical research specialists, business experts, and successful start-up founders and entrepreneurs. The company was founded in 2011 by Robert Taub, and Fabian Suarez Gonzalez has been the CEO of the company since 2022. | Direttore/Membro del Consiglio | 01/03/2020 | - |
Storia della carriera di Anneliese Monden
Statistiche
Distribuzione geografica
Belgio | 2 |
Posizioni
Director/Board Member | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Man & Science NV
![]() Man & Science NV Pharmaceuticals: MajorHealth Technology Man & Science NV is a Belgian medical device company that develops a novel, minimally invasive, battery-free neurostimulation system to reduce the pain and frequency of severe headache attacks. The company is based in Mont-Saint-Guibert, Belgium, and has subsidiaries in Norway. The company's therapies allow headache patients to return to a normal, pain-free life. The company's team consists of experienced scientists, engineers, clinical research specialists, business experts, and successful start-up founders and entrepreneurs. The company was founded in 2011 by Robert Taub, and Fabian Suarez Gonzalez has been the CEO of the company since 2022. | Health Technology |
- Borsa valori
- Insiders
- Anneliese Monden
- Esperienza